Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic

Journal of Cystic Fibrosis

Volumn 11, Issue 1, 2012, Pages 49-52

  Griffiths, Amanda L ^a   Wurzel, Danielle F ^c   Robinson, Phil J ^a,b,d   Carzino, Rosemary ^a,b   Massie, John ^a,b,d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bacterial infections; Bronchiectasis; Children; Chronic lung disease; Cross infection; Infection control; Pseudomonas aeruginosa

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTRIBUTABLE RISK; AUSTRALIAN EPIDEMIC STRAIN PSEUDOMONAS TYPE 1; BACTERIAL STRAIN; BACTERIUM CULTURE; BRONCHIECTASIS; CHILD; CHILDHOOD DISEASE; CYSTIC FIBROSIS; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD; SEGREGATION ANALYSIS;

ADOLESCENT; AUSTRALIA; BRONCHIECTASIS; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFECTION CONTROL; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

EID: 84855897502     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.08.005     Document Type: Article

References (27)

1. Schaedel C., et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002, 33(6):483-491.
2. Henry R.L., Mellis C.M., Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992, 12(3):158-161.
3. Hudson V.L., W.C., Regelmann W.E. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J Pediatr 1993, 122(6):854-860.
4. McCallum S.J., et al. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 2001, 358(9281):558-560.
5. Armstrong D.S., et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002, 166(7):983-987.
6. Bradbury R., Champion A., Reid D.W. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Respirology 2008, 13(6):886-892.
7. Group., C.F.T.I.C. Pseudomonas aeruginosa infection in people with CF: suggestions for prevention and infection control 2001, Cystic Fibrosis Trust, Bromley.
8. Group., C.T.I.C. A statement on Burkholderia Cepacia 1999, Cystic Fibrosis Trust, Bromley.
9. Branger B., RS, H.S. Recommandations pour la prevention de l'acquisition et de la transmission des germes respiratoires dans la mucoviscidose. Association Francaise Lutte Contre la Mucoviscidose 2004, [Paris].
10. Griffiths A.L., et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005, 171(9):1020-1025.
11. Massie R.J., Olsen M., Glazner J., Robertson C.F., Francis I. Newborn screening for cystic fibrosis in Victoria: 10year's experience (1989-1998). Med J Aust 2000, 172:584-587.
12. Wainwright C.E., et al. Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatr Pulmonol 2008, 43(10):965-972.
13. Wainwright C.E., et al. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. JAMA 2011, 306(2):163-171.
14. Griffiths A.L., et al. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J 2004, 24(3):449-452.
15. Armstrong D.S., et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156(4 Pt 1):1197-1204.
16. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing: Twelfth International Supplement M100-S12 2002, National Committee for Clinical Laboratory Standards, Wayne PA.
17. Cystic Fibrosis Foundation. Microbiology and Infectious Diseases in Cystic Fibrosis. Consensus Conference: Concepts in care 1994, 5. Cystic Fibrosis Foundation, Bethesda, MD, [1].
18. Armstrong D.S., et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996, 21(5):267-275.
19. Davies G., et al. Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation. Pediatr Pulmonol 2003, 35(4):253-256.
20. Tenover F.C., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33(9):2233-2239.
21. Australia CF. Infection Control Guidelines for Cystic Fibrosis Patients and Carers. In: Cystic Fibrosis Australia. 51 Wicks Rd, NSW, 2133; 2007. p. 12. http://www.cysticfibrosis.org.au/pdf/Handbook-Infection_Control.pdf.
22. Salunkhe P., et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005, 187(14):4908-4920.
23. Tingpej P., et al. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 2007, 45(6):1697-1704.
24. Smith L., et al. Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J Med Microbiol 2006, 55(Pt 12):1641-1644.
25. Festini F., et al. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect 2006, 64(1):1-6.
26. Kidd TJ R.K., Hu H., Bye P.T.P., Elkins M.R., Grimwood K., Harbour C., Marks G.B., Robinson P.J., Rose B.R., Wainwright C.E., Bell S.C. Clonal Pseudomonas aeruginosa in Australians with cystic fibrosis 2010, the ACPinCF Investigator Study Group, Thoracic Society of Australia and New Zealand, Brisbane, Australia.
27. Douglas T.A., et al. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J 2009, 33(2):305-311.